Cabasag, Tarciana B.

HRN: 22-11-02  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/15/2026
MUPIROCIN 2%, 15G (TUBE)
06/15/2026
06/22/2026
TOPICAL
Thinly
BID
IV Site Wound
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines